{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:30:41Z","timestamp":1793413841466,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T00:00:00Z","timestamp":1732838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T00:00:00Z","timestamp":1732838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100022236","name":"Office of Research and Development, University of Botswana","doi-asserted-by":"publisher","award":["REF: UBR\/RES\/Round 16"],"award-info":[{"award-number":["REF: UBR\/RES\/Round 16"]}],"id":[{"id":"10.13039\/501100022236","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-024-10258-7","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T08:34:52Z","timestamp":1732869292000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The health-related quality of life of drug-resistant tuberculosis patients receiving treatment in Botswana"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3445-6626","authenticated-orcid":false,"given":"Kebayaone P.","family":"Gare","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1952-2269","authenticated-orcid":false,"given":"Makamu","family":"Sebakeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6921-1186","authenticated-orcid":false,"given":"Mooketsi","family":"Molefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,29]]},"reference":[{"key":"10258_CR1","unstructured":"Clinical overview of drug-resistant tuberculosis disease. https:\/\/www.cdc.gov\/tb\/hcp\/clinical-overview\/drug-resistant-tuberculosis-disease.html"},{"key":"10258_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12955-019-1211-0","volume":"17","author":"AAS Jaber","year":"2019","unstructured":"Jaber AAS, Ibrahim B. Health-related quality of life of patients with multidrug-resistant tuberculosis in Yemen: prospective study. Health Qual Life Outcomes. 2019;17:1\u201314.","journal-title":"Health Qual Life Outcomes"},{"key":"10258_CR3","first-page":"75","volume-title":"Global tuberculosis Report 2023. In","author":"World Health Organization","year":"2023","unstructured":"World Health Organization. Global tuberculosis Report 2023. In. Geneva: World Health Organization; 2023. p. 75."},{"key":"10258_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12955-019-1155-4","volume":"17","author":"T Sineke","year":"2019","unstructured":"Sineke T, Evans D, Schnippel K, van Aswegen H, Berhanu R, Musakwa N, L\u00f6nnmark E, Long L, Rosen S. The impact of adverse events on health-related quality of life among patients receiving treatment for drug-resistant tuberculosis in Johannesburg, South Africa. Health Qual Life Outcomes. 2019;17:1\u201315.","journal-title":"Health Qual Life Outcomes"},{"issue":"9","key":"10258_CR5","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1111\/tmi.12146","volume":"18","author":"P Isaakidis","year":"2013","unstructured":"Isaakidis P, Rangan S, Pradhan A, Ladomirska J, Reid T, Kielmann K. I cry every day\u2019: experiences of patients co-infected with HIV and multidrug\u2010resistant tuberculosis. Tropical Med Int Health. 2013;18(9):1128\u201333.","journal-title":"Tropical Med Int Health"},{"issue":"7","key":"10258_CR6","doi-asserted-by":"publisher","first-page":"e0159560","DOI":"10.1371\/journal.pone.0159560","volume":"11","author":"N Ahmad","year":"2016","unstructured":"Ahmad N, Javaid A, Syed Sulaiman SA, Basit A, Afridi AK, Jaber AAS, Khan AH. Effects of multidrug resistant tuberculosis treatment on patients\u2019 health related quality of life: results from a follow up study. PLoS ONE. 2016;11(7):e0159560.","journal-title":"PLoS ONE"},{"key":"10258_CR7","unstructured":"Ministry of Health.: Botswana National Tuberculosis Programme TB Manual. In. Edited by Public Health, 8th edn. Gaborone, Botswana: Ministry of Health. 2017: 143."},{"key":"10258_CR8","unstructured":"Ministry of Health.: Guidelines for the Management of Drug-Resistant Tuberculosis. In. Edited by Public Health, 3rd edn. Gaborone: Ministry of Health. 2023: 144."},{"issue":"9","key":"10258_CR9","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.5588\/ijtld.13.0749","volume":"18","author":"HJ Menzies","year":"2014","unstructured":"Menzies HJ, Moalosi G, Anisimova V, Gammino V, Sentle C, Bachhuber M, Bile E, Radisowa K, Kachuwaire O, Basotli J. Increase in anti-tuberculosis drug resistance in Botswana: results from the fourth National Drug Resistance Survey. Int J Tuberc Lung Dis. 2014;18(9):1026\u201333.","journal-title":"Int J Tuberc Lung Dis"},{"key":"10258_CR10","unstructured":"Drug-resistant tuberculosis: a survival guide for clinicians, 3rd edn: Curry National Tuberculosis Center and California Department of Public Health;; 2016."},{"key":"10258_CR11","unstructured":"Sample Size Calculator for Estimating a Single Mean. http:\/\/statulator.com\/SampleSize\/ss1M.html"},{"issue":"2","key":"10258_CR12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.4103\/0253-7176.116232","volume":"35","author":"J Charan","year":"2013","unstructured":"Charan J, Biswas T. How to calculate sample size for different study designs in medical research? Indian J Psychol Med. 2013;35(2):121\u20136.","journal-title":"Indian J Psychol Med"},{"issue":"9","key":"10258_CR13","first-page":"1100","volume":"8","author":"D Chamla","year":"2004","unstructured":"Chamla D. The assessment of patients\u2019 health-related quality of life during tuberculosis treatment in Wuhan, China. Int J Tuberc Lung Dis. 2004;8(9):1100\u20136.","journal-title":"Int J Tuberc Lung Dis"},{"key":"10258_CR14","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1023\/B:QURE.0000021320.89524.64","volume":"13","author":"M-J Dion","year":"2004","unstructured":"Dion M-J, Tousignant P, Bourbeau J, Menzies D, Schwartzman K. Feasibility and reliability of health-related quality of life measurements among tuberculosis patients. Qual Life Res. 2004;13:653\u201365.","journal-title":"Qual Life Res"},{"key":"10258_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7525-7-14","volume":"7","author":"N Guo","year":"2009","unstructured":"Guo N, Marra F, Marra CA. Measuring health-related quality of life in tuberculosis: a systematic review. Health Qual Life Outcomes. 2009;7:1\u201310.","journal-title":"Health Qual Life Outcomes"},{"issue":"3","key":"10258_CR16","first-page":"296","volume":"14","author":"M Kruijshaar","year":"2010","unstructured":"Kruijshaar M, Lipman M, Essink-Bot M, Lozewicz S, Creer D, Dart S, Maguire H, Abubakar I. Health status of UK patients with active tuberculosis. Int J Tuberc Lung Dis. 2010;14(3):296\u2013302.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2","key":"10258_CR17","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1378\/chest.07-1494","volume":"133","author":"CA Marra","year":"2008","unstructured":"Marra CA, Marra F, Colley L, Moadebi S, Elwood RK, Fitzgerald JM. Health-related quality of life trajectories among adults with tuberculosis: differences between latent and active infection. Chest. 2008;133(2):396\u2013403.","journal-title":"Chest"},{"issue":"8","key":"10258_CR18","first-page":"887","volume":"11","author":"M Muniyandi","year":"2007","unstructured":"Muniyandi M, Rajeswari R, Balasubramanian R, Nirupa C, Gopi P, Jaggarajamma K, Sheela F, Narayanan P. Evaluation of post-treatment health-related quality of life (HRQoL) among tuberculosis patients. Int J Tuberc Lung Dis. 2007;11(8):887\u201392.","journal-title":"Int J Tuberc Lung Dis"},{"key":"10258_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12955-015-0337-y","volume":"13","author":"CE Mbada","year":"2015","unstructured":"Mbada CE, Adeogun GA, Ogunlana MO, Adedoyin RA, Akinsulore A, Awotidebe TO, Idowu OA, Olaoye OA. Translation, cross-cultural adaptation and psychometric evaluation of yoruba version of the short-form 36 health survey. Health Qual Life Outcomes. 2015;13:1\u201312.","journal-title":"Health Qual Life Outcomes"},{"issue":"4","key":"10258_CR20","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1177\/14034948980260040401","volume":"26","author":"J H\u00c5vard Loge","year":"1998","unstructured":"H\u00c5vard Loge J, Kaasa S. Short form 36 (SF-36) health survey: normative data from the general Norwegian population. Scand J Soc Med. 1998;26(4):250\u20138.","journal-title":"Scand J Soc Med"},{"key":"10258_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-016-1933-0","volume":"16","author":"K Schnippel","year":"2016","unstructured":"Schnippel K, Berhanu RH, Black A, Firnhaber C, Maitisa N, Evans D, Sinanovic E. Severe adverse events during second-line tuberculosis treatment in the context of high HIV co-infection in South Africa: a retrospective cohort study. BMC Infect Dis. 2016;16:1\u201310.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10258_CR22","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12955-019-1211-0","volume":"17","author":"AAS Jaber","year":"2019","unstructured":"Jaber AAS, Ibrahim B. Health-related quality of life of patients with multidrug-resistant tuberculosis in Yemen: prospective study. Health Qual Life Outcomes. 2019;17(1):142.","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"10258_CR23","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12955-019-1155-4","volume":"17","author":"T Sineke","year":"2019","unstructured":"Sineke T, Evans D, Schnippel K, van Aswegen H, Berhanu R, Musakwa N, L\u00f6nnmark E, Long L, Rosen S. The impact of adverse events on health-related quality of life among patients receiving treatment for drug-resistant tuberculosis in Johannesburg, South Africa. Health Qual Life Outcomes. 2019;17(1):94.","journal-title":"Health Qual Life Outcomes"},{"key":"10258_CR24","doi-asserted-by":"crossref","unstructured":"Araia ZZ, Mesfin AB, Mebrahtu AH, Tewelde AG, Tewelde AT, Ngusbrhan Kidane S. Health-related quality of life in tuberculosis patients in Eritrea: comparison among drug-susceptible and rifampicin\/multidrug-resistant tuberculosis patients. Patient Relat Outcome Measures. 2021:205\u201312.","DOI":"10.2147\/PROM.S316337"},{"issue":"3","key":"10258_CR25","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ijtb.2021.06.002","volume":"69","author":"U Venkatesh","year":"2022","unstructured":"Venkatesh U, Sharma A, Srivastava D, Durga R. Health-related quality of life of multidrug-resistant tuberculosis patients: a study of eastern Uttar Pradesh, India. Indian J Tuberculosis. 2022;69(3):347\u201353.","journal-title":"Indian J Tuberculosis"},{"issue":"1","key":"10258_CR26","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1186\/s12890-024-03119-1","volume":"24","author":"H Wang","year":"2024","unstructured":"Wang H, Gu J, Zhang L, Song Y. Assessing the quality of life in patients with drug-resistant tuberculosis: a cross-sectional study. BMC Pulm Med. 2024;24(1):303.","journal-title":"BMC Pulm Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-10258-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-024-10258-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-10258-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T09:02:57Z","timestamp":1732870977000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-024-10258-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,29]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["10258"],"URL":"https:\/\/doi.org\/10.1186\/s12879-024-10258-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,29]]},"assertion":[{"value":"8 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All ethical clearance procedures were followed before the start of the study. Ethical approval was obtained from the University of Botswana Institutional Review Board (IRB) under reference number UBR\/RES\/IRB\/BIO\/GRAD\/158 and the Ministry of Health Review Board under permit number HPDME: 13\/18\/1 of 01 December 2021, and permission to conduct the study on sites was granted by the PMH, NRH, SMH and GPH IRBs. All respondents were requested to sign a consent form and were informed that participation in the study is voluntary. All participants who successfully completed the study questionnaire were included in the analysis. All participants provided written informed consent before study participation. Clinical trial number: not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1367"}}